Abbott Co-Promotion Agreement Frequently Asked Questions
1. What is the co-promotion arrangement between Abbott Nutrition and Prolacta Bioscience®? Abbott Nutrition entered into a co-promotion agreement with Prolacta Bioscience, a life science company that creates specialty formulations made from human milk for the nutritional needs of premature and critically ill infants in the Neonatal Intensive Care Units (NICU). This co-promotion agreement will help to make human milk-based nutritional products more widely available for health care professional use in the NICUs of hospitals across the U.S. 2. What is the value of the Abbott Nutrition and Prolacta Bioscience co-promotion agreement to health care professionals? This co-promotion agreement increases the ability of health care professionals across the U.S. to access Prolacta products, thus giving them more options in the NICU to help support growth and development of the smallest premature infants (≤1250g/2lbs 12 oz). Abbott Nutrition will use its national reach and expertise to broaden the availability of Prolacta Bioscience 100% human milk formulations to health care providers who care for these fragile patients. Prolacta Bioscience is known for its expertise in innovative manufacturing and processing of human milk. A recent study supports providing a 100% human milk-based diet to low-birth-weight infants ≤1250 g (2lbs 12 oz).1 The addition of Prolacta formulations to Abbott Nutrition’s line of specialized nutrition products for preterm infants allows health care providers in hospital NICUs access to a broader range of feeding solutions. Abbott Nutrition is committed to ensuring optimal infant nutrition and has a long history of supporting breastfeeding with health care professionals and mothers by providing breastfeeding education materials, programs and infant nutrition products specifically designed for human milk fortification. As part of this commitment, Abbott Nutrition offers a wide range of specialized infant nutrition products designed to meet the unique needs of low-birth-weight, preterm infants treated in the NICU. 3. What are Prolacta’s products that Abbott Nutrition will be co-promoting in the NICU? Prolact+H2MF™ line of human milk fortifiers:
- Prolact+4 is formulated to fortify breast milk to a minimum of 24 Cal/fl oz. (82 Cal/100 mL). It fortifies breast milk to a target of 2.3 g of protein in 100 mL. It is available in 10mL and 20mL volumes.
- Prolact+6 is formulated to fortify breast milk to a minimum of 26 Cal/fl oz. (89 Cal/100 mL). It fortifies breast milk to a target of 2.8 g of protein in 100 mL. It is available in a 30 mL volume.
- Prolact+8 is formulated to fortify breast milk to a minimum of 28 Cal/fl oz. (97 Cal/100 mL). It fortifies breast milk to a target of 3.2 g of protein in 100 mL. It is available in 20 mL and 40 mL volumes.
- Prolact+10 is formulated to fortify breast milk to a minimum of 30 Cal/fl oz. (104 Cal/100 mL). It fortifies breast milk to a target of 3.7 g of protein in 100 mL. It is available in a 50 mL volume.

Prolacta’s products are available for health care professional use only.
1Sullivan S, Schanler RJ, Kim JH et al: An Exclusively Human Milk-Based Diet Is Associated with a Lower Rate of Necrotizing Enterocolitis than a Diet of Human Milk and Bovine Milk-Based Products. J Pediatr 2010
DOI: 10.1016/j.jpeds.2009.10.040
